Medlife starts share buyback program
Romanian private healthcare group Medlife has started on Tuesday a share buyback program that was approved by shareholders in late 2024.
Romanian private healthcare group Medlife has started on Tuesday a share buyback program that was approved by shareholders in late 2024.
The purchase price will be €0.3375 per share, inclusive of dividend, subject to possible adjustments.
The financial results reported at the end of September show total assets of €43.5 million, revenues of €10.6 million, and a net profit of €2.5 million.
The company also seeks the approval of the election of the members of EVERGENT Investments' Board of Directors for a 4-year mandate, as well as the directors' remuneration policy.
The group will offer a maximum of 174,258,721 new shares to investors. The operation starts on June 3, 2024.
Four significant shareholders of One United Properties successfully sold 234,205,285 shares in the Company to local and international institutional investors.
The value of the company increased by 23% in the two years of its presence on the capital market, and at the time of the transfer it had a capitalization of RON 234.7 million.

OMV Petrom has released its trading update for Q4 2025, revealing a period defined by improved refining performance and strategic adjustments following the extension of production licenses.
Romania's Ministry of Finance will conduct its first public offering of Fidelis government bonds for 2026 between January 16 and 23 on the Bucharest Stock Exchange. This marks the 32nd offering since the Fidelis program resumed in July 2020.
The World Bank revised down Romania's 2026 growth forecast to 1.3%, compared to the 1.9% predicted in June 2025 and 2.6% estimated in January 2025.
Romania's Finance Minister Alexandru Nazare has signed a second €500 million financing contract with the European Investment Bank (EIB) for the Sibiu-Pitești highway project.
Enery has started construction of the Ogrezeni hybrid renewable energy project in Giurgiu County, Romania.